A global collaboration helmed in New Zealand will help assess the safety of COVID-19 vaccines on a massive scale.
The Global Vaccine Data Network (GVDN), with its 21 partners in 17 countries, has been awarded funds by the US Centers for Disease Control and Prevention (CDC) to monitor 300 million people for vaccine side-effects.
The SMC asked independent experts and the project’s co-director to comment on the research.
Read Expert Reactions here
Source: Science Media Centre